[PDF] snmjournals.orgFree from Publisher

Prospective study of serial 18F-FDG PET and 18F-fluoride PET to predict time to skeletal-related events, time to progression, and survival in patients with bone …

LM Peterson, J O'Sullivan, QV Wu… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Assessing therapy response of breast cancer bone metastases is challenging. In
retrospective studies, serial 18F-FDG PET was predictive of time to skeletal-related events …
Save Cite Cited by 45 Related articles All 12 versions

18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT

A Piccardo, M Puntoni, S Morbelli… - Nuklearmedizin …, 2015 - thieme-connect.com
Aim: To compare 18 F-FDG PET/CT and 18 F-NaF PET/CT with respect to disease
prognostication and outcome in patients affected by bone metastases from breast cancer …
Save Cite Cited by 26 Related articles All 7 versions
[PDF] snmjournals.orgFree from Publisher

Assessment of bone lesions with 18F-FDG PET compared with 99mTc bone scintigraphy leads to clinically relevant differences in metastatic breast cancer …

SC van Es, T Velleman, SG Elias… - Journal of Nuclear …, 2021 - Soc Nuclear Med
It is unknown whether assessment of potential bone lesions in metastatic breast cancer
(MBC) by 18F-FDG PET instead of 99mTc bone scintigraphy (BS) supports clinically relevant …
Save Cite Cited by 13 Related articles All 7 versions
[PDF] rsna.orgFull View

18F-FDG PET/CT for the Evaluation of Therapy Response in Hormone Receptor–Positive Bone-Dominant Metastatic Breast Cancer

I Makhlin, KE Korhonen, ML Martin, J Gillman… - Radiology: Imaging …, 2022 - pubs.rsna.org
Fluorine 18 (18F) fluorodeoxyglucose (FDG) PET/CT has shown promise for use in
assessing treatment response in patients with bone-only or bone-dominant (BD) metastatic …
Save Cite Cited by 10 Related articles All 5 versions
[PDF] snmjournals.orgFree from Publisher

18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer

U De Giorgi, M Mego, EM Rohren, P Liu… - Journal of Nuclear …, 2010 - Soc Nuclear Med
Our objective was to compare the predictive significance of 18F-FDG PET/CT findings and
circulating tumor cell (CTC) count in patients with bone metastases from breast cancer …
Save Cite Cited by 83 Related articles All 13 versions
[HTML] nih.gov

[HTML][HTML] 18F-fluoride PET/CT tumor burden quantification predicts survival in breast cancer

AE Brito, A Santos, AD Sasse, C Cabello, P Oliveira… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Purpose In bone-metastatic breast cancer patients, there are no current imaging biomarkers
to identify which patients have worst prognosis. The purpose of our study was to investigate …
Save Cite Cited by 24 Related articles All 8 versions

Serial 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to …

JM Specht, SL Tam, BF Kurland, JR Gralow… - Breast cancer research …, 2007 - Springer
Background The response of bone-dominant (BD) breast cancer to therapy is difficult to
assess by conventional imaging. Our preliminary studies have shown that quantitative serial …
Save Cite Cited by 110 Related articles All 12 versions
[HTML] nih.gov

Usefulness of 18F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases

SH Yoon, KS Kim, SY Kang, HS Song, KS Jo… - Nuclear medicine and …, 2013 - Springer
Purpose Bone metastasis is an important factor for the treatment and prognosis of breast
cancer patients. Whole-body bone scintigraphy (WBBS) can evaluate skeletal metastases …
Save Cite Cited by 44 Related articles All 11 versions
[HTML] springer.com

[HTML][HTML] Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial …

NM Bruckmann, J Kirchner, L Umutlu, WP Fendler… - European …, 2021 - Springer
Objectives To compare the diagnostic performance of [18F] FDG PET/MRI, MRI, CT, and
bone scintigraphy for the detection of bone metastases in the initial staging of primary breast …
Save Cite Cited by 41 Related articles All 9 versions

Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy

SE Stafford, JR Gralow, EK Schubert, KJ Rinn… - Academic radiology, 2002 - Elsevier
RATIONALE AND OBJECTIVES: The authors performed this study to determine the
feasibility of using quantitative 2-[fluorine-18] fluoro-2-deoxy-d-glucose (FDG) positron …
Save Cite Cited by 174 Related articles All 6 versions